A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy — Stella
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
(3 sites) United States
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte, North Carolina Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina Aurora St. Luke's Medical Center MOB, Milwaukee, Wisconsin
Key details Sponsor
Wake Forest University Health Sciences
Collaborators
Atrium Health Wake Forest Baptist
Enrollment target
~35 participants
Primary completion
August 2029
Last updated February 2026